GLP-1R Agonists and Their Therapeutic Potential in Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory Diseases, a Systematic Review of the Literature.

[ 45 ] found that giving GLP1RAs decreased the infiltration of dermal γδT cells into the skin of PsO patients and that this decrease strongly correlated with the decrease in PASI scores (r = 0.894, p = 0.007), whilst the decrease in IL-17 expression did not reach statistical significance.

also in 111,027 other papers